Efficacy of the herbal hepatoprotector in patients with coronary artery disease after PCI

doi:10.5083/ejcm

Contents

Abstract
Keywords

Download XML

598 Views

212 Downloads

Share this article

Research Article | Volume 11 Issue :4 (, 2021) | Pages 36 - 40

Efficacy of the herbal hepatoprotector in patients with coronary artery disease after PCI

Under a Creative Commons license

Open Access

DOI : 10.5083/ejcm

Published

Dec. 25, 2021

Abstract

Coronary artery disease (CAD) is leading due to disability and death of the working population, and successful its treatment is largely determined by maintaining adequate coronary blood flow, including through interventions, percutaneous interventions. This article describes the efficacy of the adding herbal hepatoprotector - Hepofresh 2 tablets 3 times a day on the framework of the standard therapy on some indicators of the functional state of the liver of patients with coronary heart disease with stable angina of III-IV FC, subjected to percutaneous intervention (PCI). And the results show that Hepofresh contributes to better tolerance of treatment, increases its effectiveness and prevent the development of side effects and various liver disorders in patients CAD after PCI.

Keywords

Coronary artery disease

Percutaneous intervention

Aspirin

Clopidogrel

Statin

European Journal of Cardiovascular Medicine

Download PDF